From: Who knew? The misleading specificity of “double-blind” and what to do about it
Group or individual blindeda | Information withheldb | Method of blindingc,d | Blinding compromised |
---|---|---|---|
Required fields to be completed for all trials described as blinded | |||
Person assigning participants to groups | Group assignment | Concealed allocation schedule | No |
Participants | Group assignment | Placebo medications; sham surgeries | No |
Care providers | Group assignment | Not told of group assignment | No |
Data collectors and managers | Group assignment | Not told of group assignment | No |
Outcome assessors | Purpose of study; group assignment; participant characteristics | Participants given numerical identifiers | No |
Statisticians | Participant and group identities | Participants and groups given numerical identifiers | No |
Supplemental fields for all blinded groups or individuals not mentioned above | |||
Trial manager | Not applicable | . . . | . . . |
Pharmacists | Not applicable | . . . | . . . |
Laboratory technicians | Participant identities | Participants given numerical identifiers | |
Outcome adjudicators | Group assignment | Groups given numerical identifiers | Yes [put details in text] |
Data monitoring and safety committees | Not applicable | . . . | . . . |
Manuscript writers | Not blinded | . . . | . . . |